Quantitative comparison of mean macular thickness in COVID-19 patients versus healthy individuals using optical coherence tomography

Abstract Background SARS-CoV-2 is associated with systemic inflammation, vascular dysfunction, and potential ocular involvement. While structural retinal changes have been observed in some patients, the long-term impact of COVID-19 on macular architecture remains unclear, §particularly in unvaccinat...

Full description

Saved in:
Bibliographic Details
Main Authors: Nagilton Bou Ghosn, Marcos Balbino, Ana Carolina Pasquini Raiza, Camila Sayuri Vicentini Otani, Victoria Moreira Fernandes, Vitor Kazuo Lotto Takahashi, Beatriz Silveira Seixas, Laura Vanalli Guimarães, Luiz Paulo Dias Mario, Regina Cele Silveira Seixas
Format: Article
Language:English
Published: BMC 2025-08-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-025-04177-7
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background SARS-CoV-2 is associated with systemic inflammation, vascular dysfunction, and potential ocular involvement. While structural retinal changes have been observed in some patients, the long-term impact of COVID-19 on macular architecture remains unclear, §particularly in unvaccinated populations. Objective To evaluate differences in central macular thickness (CMT) between post-COVID-19 patients and healthy individuals using optical coherence tomography (OCT), with age-stratified analysis. Design A prospective case-control study conducted at a specialized ophthalmology center in Brazil during the early vaccination phase. A total of 76 unvaccinated participants were included: 29 patients with prior COVID-19 (58 eyes) and 47 healthy controls (94 eyes). OCT was performed at least 14 days after PCR-confirmed infection. Results The overall mean CMT was 246.93 ± 23.30 μm. No significant difference was found between the COVID-19 and control groups (242.54 ± 19.76 μm vs. 249.63 ± 25.06 μm; p = 0.10). However, among participants aged ≥ 42 years, post-COVID-19 patients had significantly lower CMT compared to age-matched controls (241.00 ± 21.90 μm vs. 256.85 ± 28.58 μm; p = 0.04). No significant difference was observed in the < 42 years group. OCT angiography revealed no qualitative vascular abnormalities in either group. Conclusion Our findings suggest that SARS-CoV-2 infection may be associated with subtle retinal thinning in older adults, even in the absence of acute symptoms or visual complaints. These results highlight the importance of age-stratified analysis and support further investigation into the long-term ocular effects of COVID-19.
ISSN:1471-2415